Could a Two-Drug combo save more cardiac arrest patients?
NCT ID NCT00127907
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding vasopressin to the standard drug epinephrine helps more people survive a cardiac arrest that happens outside the hospital. Over 2,400 adults were enrolled. The main goal was to see how many patients were alive when they reached the hospital.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- epinephrine and vasopressin
- What this could lead to
- If it works, this could improve survival rates for people who suffer a cardiac arrest outside the hospital.
- What could go wrong
- This is a completed Phase 4 trial, but earlier studies showed mixed results. The benefit may be small or limited to certain patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cooling after cardiac arrest change how the body burns fuel?
- Double shocks: could two defibrillators save more cardiac arrest patients?
- Could a smarter breathing machine boost survival after cardiac arrest?
- Balloon in the aorta could boost CPR success in cardiac arrest
- Can an education program ease caregiver trauma after a Child's cardiac arrest?
- Brain rescue: dual drug attack on Post-Arrest seizures shows promise